We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

55 hedge funds and large institutions have $1.15M invested in Oncolytics Biotech in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

52% more capital invested

Capital invested by funds: $756K → $1.15M (+$395K)

8% more funds holding

Funds holding: 51 → 55 (+4)

0.01% less ownership

Funds ownership: 1.59% → 1.59% (-0.01%)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SI
Seeds Investor
New York
+$17.9K
2
Goldman Sachs
Goldman Sachs
New York
+$11.2K
3
Jane Street
Jane Street
New York
+$10.8K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$10.6K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$10.6K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K
2
LPL Financial
LPL Financial
California
-$8.88K
3
TSS
Two Sigma Securities
New York
-$8.34K
4
GSC
Ground Swell Capital
South Carolina
-$7.97K
5
IFG
Independent Financial Group
California
-$6.08K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
26
PFG Investments
New York
$10.8K +$530 +1,000 +8%
Creative Planning
27
Creative Planning
Kansas
$10.3K – – –
Toronto Dominion Bank
28
Toronto Dominion Bank
Ontario, Canada
$9.86K +$6.84K +12,908 New
XT
29
XTX Topco
Cayman Islands
$9.76K +$6.69K +12,631 New
AFP
30
Ausdal Financial Partners
Iowa
$9.28K -$1.27K -2,400 -17%
Cambridge Investment Research Advisors
31
Cambridge Investment Research Advisors
Iowa
$9K +$5.97K +11,271 New
KWM
32
Kingsview Wealth Management
Oregon
$8.66K – – –
Cerity Partners
33
Cerity Partners
New York
$7.73K +$5.3K +10,000 New
SFI
34
SPC Financial Inc
Maryland
$7.73K +$5.3K +10,000 New
AF
35
Allworth Financial
California
$6.53K – – –
Osaic Holdings
36
Osaic Holdings
Arizona
$5.19K +$1.85K +3,496 +106%
VNA
37
Valley National Advisers
Pennsylvania
$5K +$609 +1,150 +20%
Raymond James Financial
38
Raymond James Financial
Florida
$4.99K +$3.42K +6,450 New
CMA
39
Cedar Mountain Advisors
Oregon
$4.37K – – –
AWM
40
Activest Wealth Management
Florida
$3.87K – – –
Wells Fargo
41
Wells Fargo
California
$3.4K – – –
BlackRock
42
BlackRock
New York
$2.32K – – –
Jones Financial Companies
43
Jones Financial Companies
Missouri
$1.54K +$1.09K +2,053 New
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
AAS
45
Ameritas Advisory Services
Nebraska
$580 +$397 +750 New
MCM
46
MAI Capital Management
Ohio
$407 – – –
TWC
47
TD Waterhouse Canada
Ontario, Canada
$299 – – –
Citigroup
48
Citigroup
New York
$254 +$176 +333 New
DWM
49
Dogwood Wealth Management
Kansas
$182 – – –
JFA
50
JNBA Financial Advisors
Minnesota
$163 – – –
1
2
3

ONCY Hedge Fund Activity: Q2 2025 in Review

55 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q2 2025, worth a combined $1.15M — up 52% from $756K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ONCY positions and 7 closed out — a net gain of 4 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Seeds Investor, adding an estimated $17.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $11K sold.

  • 55 institutional investors held Oncolytics Biotech (ONCY) as of Q2 2025, up from 51 in Q1 2025.
  • Funds reported $1.15M of Oncolytics Biotech stock for Q2 2025, up 52% quarter-over-quarter.
  • 11 funds opened new Oncolytics Biotech positions in Q2 2025 and 7 closed out, a net change of +4 holders.
  • The largest Oncolytics Biotech buyer in Q2 2025 was Seeds Investor, an estimated $17.9K added.
  • The largest Oncolytics Biotech seller in Q2 2025 was Susquehanna International Group, an estimated $11K sold.

Based on aggregated 13F filings for Q2 2025.